UNSPSC 51284127: Cefetamet pivaloyloxymethyl ester

This classification denotes a cephalosporin antibiotic with the molecular formula C20H25N5O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F6XA85N260, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r-(6.alpha.,7.beta.(z)))-, but more generally known as cefetamet pivaloyloxymethyl ester, which bears US NIH Compound Identifier 5485222.

European Medicines Agency schedules cefetamet pivaloyloxymethyl ester or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07391MIG. Most nations, for tariff purposes, schedule cefetamet pivaloyloxymethyl ester under HS 29419000. SMILES: CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3CSC(N3)N)SC1)C(=O)OCOC(=O)C(C)(C)C.

UNSPSC 51284127 Cefetamet pivaloyloxymethyl ester is a Commodity code nominally identifying a specific pharmaceutical compound, but recent state and local solicitations tagged to this code do not reflect procurement of that active ingredient. Instead, the code shows activity in broader pharmaceutical and medical supply procurement, including naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers. The actual work being solicited under this code spans public health departments, fire rescue divisions, and state health agencies seeking to establish supply agreements for pharmaceutical products, medical consumables, and emergency response materials through competitive bidding processes (IFB, RFP, RFI) and cooperative purchasing arrangements. Issuing bodies include county health departments, municipal fire services, and state agencies administering multi-jurisdictional cooperative purchasing programs.

Recent activity shows geographic concentration in Florida and Minnesota, with significant involvement from multi-state procurement platforms. Representative solicitations include Seminole County, Florida's IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with response due July 26, 2023; the City of Tampa's IFB 26P00145 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000.00, response deadline March 13, 2026, sheltered exclusively for certified Small Local Business Enterprises (SLBEs) with a 5 percent bid discount not to exceed $10,000; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, with proposals due March 26, 2026 and contract effective July 1, 2026; and the Texas Health and Human Services Commission RFI HHS0017013 for direct-to-manufacturer prescription program capabilities, response due April 3, 2026. The code shows limited relevant activity — the mismatch between the nominal pharmaceutical compound and the actual scope of procured products and services suggests this classification may not consistently align with the work being sourced.